|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.310 USD | +0.23% |
|
-6.94% | +50.53% |
| 06-29 | Lifeward Ltd. announced that it expects to receive $11.16 million in funding from Oramed Pharmaceuticals Inc. | CI |
| 06-29 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 5 | 5 | 4.67 |
| Spread/Res. | -14.20% | -14.20% | -8.14% |
| Spread/Supp. | +4.38% | +11.72% | +39.74% |
| Support | 4.11 | 3.84 | 3.07 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORMP Stock
- Charts Oramed Pharmaceuticals Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
